Open Nav

Biotech/Pharma Company

Corporations or other entities that use biotechnology or related technologies for research and development of products or information.

Discovery Track Company

Corporations qualifying for the Discovery Track rates include only the following: Discovery Track corporations are "pre-emerging" biotech companies, qualifying as seed and A-round companies incorporated after December 31, 2010, that have raised, or are looking to raise, less than $25M total through October 2015. For this event, Discovery Track companies must use biotechnology or related technologies for research and development of drug products or diagnostics. For those companies that want the Discovery Track rate for a company presentation, they also must be first-time presenters at the BIO Investor Forum.

Group Package

Register as a group and save up to 20% off regular registration rates.All biotech and pharma companies are eligible to receive the discounted group registration rates. A minimum of 3 individuals from the same organization must register in order to qualify for the discount. Please note: The group package rate does NOT include a corporate presentation. 


BIO events attract the most sophisticated investors in the life science community and provide a robust forum for this community to engage in the advancement of promising technologies that improve and save lives. BIO is pleased to provide complimentary registration to qualified investors under BIO’s investor policy which has been clarified for 2015.

Qualified investors are defined as institutional, private equity, angel and venture investors with funds on-hand, whose primary activity is direct investment in research and development companies (e.g., hedge fund, mutual fund, or venture fund). Equity research analysts from investment banking institutions and buy-side analysts also qualify as investors. At BIO’s discretion, qualified investors may also include crowd funding companies and, potentially “accredited investors,” who have gained importance to the biotech industry under the JOBS Act.

The fund name, portfolio type, or other helpful information is needed for BIO to process your registration appropriately. Receipt of complimentary registration for a prior year's event does not automatically qualify a registrant for complimentary registration in 2015.

Academic/Government/Non-Profit (A Code is Required)

Attendees affiliated with accredited government or academic institution. Attendees must show proof through business card or ID on-site. To be eligible for the non-profit registration category, the attendee must show proof of working for an organization that has already received 501(c)(3) status from the Internal Revenue Service. Please send an email to to request a code.

Media Registration

Media registration is open to editors and reporters working full time for print, broadcast or web publications with valid press credentials. Advance media registration for the BIO Investor Forum will be available Monday, July 6 – Friday, October 16. Onsite registration will be available starting Tuesday, October 20. 

Service Providers/Suppliers

Corporations or other for-profit entities that provide services or products to biotechnology and other companies. Service providers include investment and merchant bankers and representatives of law, accounting, consulting, contract manufacturers, active pharmaceutical ingredient manufacturers, contact research organizations, real estate development, and economic development organizations. Service providers cannot register with presenting companies unless approved by BIO and do not receive access to BIO One-on-One PartneringTM. For service providers to access the conference’s online partnering system, the organization must sponsor at a specific level. For information about becoming a sponsor, please contact George MacDougall at 202.962.6689 or gmacdougall(at)

For the purposes of registration for any BIO event, conference or meeting, the classification of a registrant as a research and development company, academic & government or a qualifying investor is subject to review by BIO. In its sole discretion, BIO reserves the right to make the determination of the proper classification of a registrant. Depending on this classification, an additional registration fee maybe required. BIO reserves the right to publish materials and restrict conference and/or partnering system access consistent with these determinations.